PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion VaccineJacalyn Rosenblatt, David Avigan, Brett Glotzbecker et al.|Journal of Immunotherapy|2011Cited by 285
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myelomaJacalyn Rosenblatt, David Avigan, Baldev Vasir et al.|Blood|2010Cited by 228
Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma PatientsJacalyn Rosenblatt, David Avigan, Irit Avivi et al.|Clinical Cancer Research|2013Cited by 209
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia R. Pyzer, David Avigan, Dina Stroopinsky et al.|Blood|2017Cited by 193
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, David Avigan, Richard M. Stone et al.|Science Translational Medicine|2016Cited by 165